Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | +0.76% | -3.86% | -24.29% |
Mar. 13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
Mar. 12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.29% | 255M | |
+73.09% | 12.37B | |
-18.39% | 7.96B | |
+14.33% | 7.09B | |
+3.74% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4B | |
-35.92% | 2.41B | |
+1.73% | 2B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Canaccord Genuity Upgrades Bioventus to Buy From Hold, Adjusts Price Target to $7 From $3.66